Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
Tax Provision
Sonoma Pharmaceuticals Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Tax Provision
$27k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Tax Provision
-$3.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Tax Provision
-$400m
|
CAGR 3-Years
43%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-3%
|
|
Pfizer Inc
NYSE:PFE
|
Tax Provision
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Tax Provision
-$1.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Tax Provision
-$1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-1%
|
See Also
What is Sonoma Pharmaceuticals Inc's Tax Provision?
Tax Provision
27k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Tax Provision amounts to 27k USD.
What is Sonoma Pharmaceuticals Inc's Tax Provision growth rate?
Tax Provision CAGR 1Y
-89%
Over the last year, the Tax Provision growth was -89%.